The Texas attorney general has sued leading insulin manufacturers and pharmacy benefit managers (PBMs), accusing them of collaborating to inflate the cost of insulin.
Texas Attorney General Ken Paxton’s office said on Thursday it had sued insulin makers Eli Lilly, Novo Nordisk and Sanofi.
The office had also sued PBMs, including CVS’ Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx, who act as intermediaries in negotiating drug prices and coverage.
Why It’s Important
The lawsuit targets both insulin manufacturers and PBMs. The previous action by U.S. antitrust regulators only targeted PBMs.
The U.S. Federal Trade Commission,